About Pfizer Inc.
Pfizer Inc. is an American multinational biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes prescription medicines and vaccines worldwide. German entrepreneurs Charles Pfizer and Charles F. Erhart founded it in 1849 in New York. The company went public on June 22, 1942, and is listed on the New York Stock Exchange under the ticker symbol PFE. Pfizer operates in the pharmaceuticals and biotechnology industry within the healthcare sector. Its major business segments are Biopharma, PC1, and Pfizer Ignite. Key products and brands include the Prevnar family of pneumococcal vaccines, Abrysvo, Paxlovid, Eliquis, Ibrance, Xtandi, Xeljanz, Enbrel, and Nurtec ODT. Pfizer is one of the largest pharmaceutical companies in the world by revenue and sells products across multiple therapeutic areas.
Island secures $400M funding, reaches $6.4B valuation amid AI security demand
Island's rapid growth highlights the increasing importance of cybersecurity in AI, potentially reshaping enterprise security strategies globally.
Charles Schwab launches single stock futures for over 50 US stocks
Schwab's launch of single stock futures could democratize access to leveraged trading, potentially increasing market participation and volatility.
S&P 500 dividend yield hits historic low as just 5 members still offer 6% or more
The historic low S&P 500 dividend yield highlights a shift towards capital gains over income, challenging income-focused investors' strategies.
Chai Discovery unveils Chai-3, advancing AI drug design capabilities
Chai-3's advancements could revolutionize drug discovery, significantly reducing time and costs, and potentially transforming the biotech industry.
Chai Discovery raises $400M for AI drug discovery as big pharma bets on machine learning over blockchain
AI's success in drug discovery highlights its potential to revolutionize the industry, challenging the need for blockchain-based solutions.
US Treasury assesses options to screen investments in China biotech
Heightened scrutiny of US-China biotech investments could reshape global pharmaceutical collaborations, impacting innovation and market dynamics.
A sourced map of Pfizer Inc.'s relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Pfizer Inc. and the wider market, hosted by our team, will appear here once episodes are live.